96 related articles for article (PubMed ID: 10656691)
21. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
22. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells.
Kang DW; Min do S
Cancer Lett; 2010 Aug; 294(1):125-33. PubMed ID: 20188462
[TBL] [Abstract][Full Text] [Related]
23. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways.
Jeon ES; Kang YJ; Song HY; Im DS; Kim HS; Ryu SH; Kim YK; Kim JH
Cell Signal; 2005 Jun; 17(6):777-87. PubMed ID: 15722202
[TBL] [Abstract][Full Text] [Related]
24. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
25. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
[TBL] [Abstract][Full Text] [Related]
26. PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: effects of altered intracellular Ca2+ regulation.
Egan CG; Wainwright CL; Wadsworth RM; Nixon GF
Cardiovasc Res; 2005 Aug; 67(2):308-16. PubMed ID: 15885673
[TBL] [Abstract][Full Text] [Related]
27. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
[TBL] [Abstract][Full Text] [Related]
28. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
29. Relationship between phospholipase D activation and endothelial vasomotor dysfunction in rabbit aorta.
Cox DA; Cohen ML
J Pharmacol Exp Ther; 1997 Oct; 283(1):305-11. PubMed ID: 9336337
[TBL] [Abstract][Full Text] [Related]
30. Role of Rho family proteins in phospholipase D activation by growth factors.
Hess JA; Ross AH; Qiu RG; Symons M; Exton JH
J Biol Chem; 1997 Jan; 272(3):1615-20. PubMed ID: 8999836
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
Esteve P; del Peso L; Lacal JC
Oncogene; 1995 Dec; 11(12):2657-65. PubMed ID: 8545123
[TBL] [Abstract][Full Text] [Related]
32. [Mechanism of phospholipase D regulation].
Nakamura S
Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1007-12. PubMed ID: 10396976
[No Abstract] [Full Text] [Related]
33. [Phospholipase D. New pathways of signal transduction].
Höer A; Oberdisse E
Med Monatsschr Pharm; 1996 May; 19(5):122-31. PubMed ID: 8684308
[No Abstract] [Full Text] [Related]
34. Multiple forms of phospholipase D in plants: the gene family, catalytic and regulatory properties, and cellular functions.
Wang X
Prog Lipid Res; 2000 Mar; 39(2):109-49. PubMed ID: 10775762
[TBL] [Abstract][Full Text] [Related]
35. [Roles of phospholipase D in signal transduction].
Nakashima S; Nozawa Y
Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):998-1006. PubMed ID: 10396975
[No Abstract] [Full Text] [Related]
36. Regulation of ras proteins and their involvement in signal-transduction pathways (review).
Lacal J; Carnero A
Oncol Rep; 1994 Jul; 1(4):677-93. PubMed ID: 21607423
[TBL] [Abstract][Full Text] [Related]
37. Interaction between RAS gene and lipid metabolism in cancer.
Zhang M; Pan J; Huang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):17-22. PubMed ID: 34117852
[TBL] [Abstract][Full Text] [Related]
38. The Metabolic Underpinnings of Ferroptosis.
Zheng J; Conrad M
Cell Metab; 2020 Dec; 32(6):920-937. PubMed ID: 33217331
[TBL] [Abstract][Full Text] [Related]
39. PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia.
Saliakoura M; Rossi Sebastiano M; Pozzato C; Heidel FH; Schnöder TM; Savic Prince S; Bubendorf L; Pinton P; A Schmid R; Baumgartner J; Freigang S; Berezowska SA; Rimessi A; Konstantinidou G
Nat Cell Biol; 2020 Nov; 22(11):1382-1395. PubMed ID: 33077911
[TBL] [Abstract][Full Text] [Related]
40. AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control.
González A; Hall MN; Lin SC; Hardie DG
Cell Metab; 2020 Mar; 31(3):472-492. PubMed ID: 32130880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
